Clinical trial
Galantamine Executive Function in Parkinson's Disease
NCT00211588 · Memorial Hospital of Rhode Island, Other · Unknown status
Key facts
| NCT number | NCT00211588 |
|---|---|
| Title | Galantamine Executive Function in Parkinson's Disease |
| Official title | Investigator Initiated Study: Galantamine CR Potential Enhancement of Attentional and Executive Function in Non-Demented Patients With Parkinson's Disease |
| Lead sponsor | Memorial Hospital of Rhode Island, Other |
| Collaborators | Ortho-McNeil Neurologics, Inc. Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | galantamine |
| Enrollment | 90 |
| Start date | Jun 1, 2004 |
| Completion | May 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | May 7, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: